GL1X · GenesisL1 explorer

MolNFT v1 · #125545 · protein

Structure of the human quinone reductase 2 (NQO2) in complex with pacritinib

5LBZ: “Structure of the human quinone reductase 2 (NQO2) in complex with pacritinib”. X-ray diffraction, 4 ligands (FAD, 6T3, ZN). MolNFT v1 #125545 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5LBZ
Type
protein
Length
454 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P16083
Ligands
FAD, 6T3, ZN, SO4

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B—protein227—P16083

Ligands and binding sites

  • FAD · Flavin-adenine dinucleotide · ligand · 2 copies · chains A, B
  • 6T3 · 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5LBZ · Structure of the human qui reductase 2 (NQO2) in complex with pacritinib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.